RIM
RVMD icon

Rakuten Investment Management’s Revolution Medicines RVMD Stock Holding History

Rakuten Investment Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$21K Hold
475
– – ﹤0.01% 523
2024
Q2 		$18.3K Buy
475
+150
+46% +$5.61K ﹤0.01% 531
2024
Q1 		$10.5K Hold
325
– – ﹤0.01% 532
2023
Q4 		$9.54K Buy
+325
New +$7.81K ﹤0.01% 480

Other funds holding RVMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Rakuten Investment Management's RVMD Position: Q3 2024 in Review

Rakuten Investment Management held its Revolution Medicines (RVMD) position steady in Q3 2024 at 475 shares worth $21K. The position accounts for ﹤0.01% of the portfolio, ranked #523.

Rakuten Investment Management first reported a position in RVMD in Q4 2023 and has held it in 4 quarters since. 255 funds tracked by Wall St. Rank hold RVMD as of Q3 2024.

  • Rakuten Investment Management held 475 shares of Revolution Medicines worth $21K as of Q3 2024.
  • Rakuten Investment Management left its Revolution Medicines share count unchanged in Q3 2024.
  • Revolution Medicines made up ﹤0.01% of Rakuten Investment Management's portfolio in Q3 2024, its #523 holding.
  • Rakuten Investment Management first reported a position in Revolution Medicines in Q4 2023 and has held it in 4 quarters since.
  • 255 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2024.

Based on Rakuten Investment Management's 13F filing for Q3 2024, filed 15 May 2025.